91¶¶Òõ

It’s time to start off another busy day of trading with a dive into the biggest pre-market stock movers for Tuesday!

Source: f11photo/Shutterstock.com

Let’s get into that news below!

Pre-Market Stock Movers: 10 Top Gainers

1. ToughBuilt Industries (NASDAQ:TBLT) stock is rocketing more than 42% .
2. Sharps Technology (NASDAQ:STSS) stock is gaining over 29% .
3. AIM ImmunoTech (NYSEMKT:AIM) shares are surging more than 18% on no clear news this morning.
4. Sidus Space (NASDAQ:SIDU) stock is soaring over 17% as it bounces back from a dip yesterday.
5. Navidea Biopharmaceutical (NYSEMKT:NAVB) shares are rising more than 17% .
6. 4d pharma (NASDAQ:LBPS) stock is increasing over 15% in pre-market trading this morning.
7. CNS Pharmaceuticals (NASDAQ:CNSP) shares are climbing more than 13% as it recovers from a similar fall on Monday.
8. Qutoutiao (NASDAQ:QTT) stock is sitting over 12% higher this morning.
9. Guardforce AI Co (NASDAQ:GFAI) shares are getting a more than 12% boost following a major drop yesterday.
10. Super Micro Computer (NASDAQ:SMCI) stock is up over 12% .

10 Top Losers

1. System1 (NYSE:SST) stock is plummeting more than 27% .
2. Cassava Sciences (NASDAQ:SAVA) shares are diving over 18% .
3. Enservco (NYSEMKT:ENSV) stock is tumbling more than 18% as it retreats from a rally on Monday.
4. Indonesia Energy (NYSEMKT:INDO) shares are taking a nearly 9% beating on no apparent news this morning.
5. Casa Systems (NASDAQ:CASA) stock is dropping over 8% .
6. Frequency Therapeutics (NASDAQ:FREQ) shares are falling close to 8% as it pulls back after a rally on Monday.
7. IT Tech Packaging (NYSEMKT:ITP) stock is decreasing more than 7% following a run higher yesterday.
8. ACADIA Pharmaceuticals (NASDAQ:ACAD) shares are slipping over 7% .
9. BioCardia (NASDAQ:BCDA) stock is dipping more than 7%, which continues its recent negative movement.
10. TG Therapeutics (NASDAQ:TGTX) shares close out our pre-market stock movers down over 7% .

On the date of publication, William White did not have (either directly or indirectly) any positions in the securities mentioned in this article. The opinions expressed in this article are those of the writer, subject to the InvestorPlace.com Publishing Guidelines.